The Research Progress on the Interval Selection and Efficacy Evaluation Between Multiple 131I Treatments for Differentiated Thyroid Cancer with Distant Metastasis

SHI Lei, ZHANG Huimin, XIE Qian, HU Desheng

PDF(959 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(959 KB)
Labeled Immunoassays and Clinical Medicine ›› 2022, Vol. 29 ›› Issue (6) : 1071-1074. DOI: 10.11748/bjmy.issn.1006-1703.2022.06.035
Review

The Research Progress on the Interval Selection and Efficacy Evaluation Between Multiple 131I Treatments for Differentiated Thyroid Cancer with Distant Metastasis

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2022, 29(6): 1071-1074 https://doi.org/10.11748/bjmy.issn.1006-1703.2022.06.035

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(959 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉